Antiangiogenic therapies, aimed at inhibiting tumor neovascularization by blocking signaling pathways such as VEGF, limit the supply of nutrients and oxygen to cancer cells, thereby reducing tumor growth [216]. This evidence concerns the gene VEGFA and neoplasm.